04
Mon, Mar
42 New Articles

NKO Partners and Stanivuk & Manasijevski Advise on Dr. Max Group's Acquisition of AU Medis Lek

NKO Partners and Stanivuk & Manasijevski Advise on Dr. Max Group's Acquisition of AU Medis Lek

Serbia
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

NKO Partners has advised the Dr. Max Group on its acquisition of the AU Medis Lek pharmacy chain in Serbia. Stanivuk & Manasijevski advised AU Medis Lek's shareholder on the sale.

The Dr. Max Group is a Prague-headquartered pharmacy chain operating in Central and Eastern Europe. The company has over 2,200 pharmacies in six countries, including the Czech Republic, Slovakia, Poland, Romania, Serbia, and Italy.

AU Medis Lek is a Nis-based pharmacy chain in Serbia.

NKO Partners, just last year, advised the Dr. Max Group on its acquisition of the Sveti Sava Pharmacies (as reported by CEE Legal Matters on December 7, 2022), the K-Pharma chain (as reported on June 8, 2022), the Janja pharmacy chain (as reported on March 28, 2022), and the Zlatni Lav pharmacies (as reported on January 5, 2022).

The NKO Partners team included Partner Djordje Nikolic and Senior Associate Branko Jankovic.

The Stanivuk & Manasijevski team was led by Partner Bojan Stanivuk and included Partner Bojan Manasijevski and Attorney-at-Law Marko Perovic.

Our Latest Issue